<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, April 16, 2018 (HealthDay News) — One- and two-hour plasma glucose concentrations (1h-PG and 2h-PG, respectively) are similarly effective at predicting diabetic retinopathy (DR), according to a study published online April 5 in Diabetes Care<\/i>.<\/p>\n
Ethan Paddock, from the National Institutes of Health in Phoenix, and colleagues assessed the ability of 1h-PG and 2h-PG, derived from a 75-g oral glucose tolerance test (OGTT), to predict DR among an American Indian community in the southwestern United States. The authors assessed cross-sectional and longitudinal cohorts of 2,895 and 1,703 individuals, respectively.<\/p>\n
The researchers found that the prevalence and incidence of DR changed in a similar manner across the distributions of 1h-PG and 2h-PG concentrations. Overall, 1h-PG and 2h-PG showed similar value in identifying prevalent and incident DR using direct ophthalmoscopy. The cut points of 230 (type 2 diabetes) and 173 mg\/dL (impaired glucose tolerance) in the 1h-PG were comparable to 2h-PG cut points of 200 mg\/dL and 140 mg\/dL, respectively.<\/p>\n
“1h-PG is a useful predictor of retinopathy risk, has a predictive value similar to that of 2h-PG, and may be considered as an alternative glucose time point during an OGTT,” the authors write.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n